Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Icahn School of Medicine at Mount Sinai
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Juan J Badimon, Icahn School of Medicine at Mount Sinai
ClinicalTrials.gov Identifier:
NCT01823510
First received: March 29, 2013
Last updated: January 12, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)